Brief: Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride delayed release capsules
Jan 9 (Reuters) - Ajanta Pharma Ltd AJPH.NS :
* Says Ajanta Pharma announces US FDA approval for
Duloxetine Hydrochloride delayed release capsules
* Says company will be launching the product shortly in 3
strengths, 20 mg, 30 mg and 60 mg strengths capsules
Source text: http://bit.ly/2i9tdsI
Further company coverage: AJPH.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility